Insider Trading History of Watts Ryan J.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Watts Ryan J. since year 2005. The trader's CIK number is 1724310. At the time of the last reporting, Watts Ryan J. was the President and CEO of Denali Therapeutics Inc. . (stock ticker symbol DNLI). See this page for all insider trading activities at Denali Therapeutics Inc. .


Stock purchases, sales, and option exercises reported by insider Watts Ryan J. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-06-03 DNLI Denali Therapeutics Inc. Sale 18,333 19.07 349,610
2019-05-01 DNLI Denali Therapeutics Inc. Sale 6,112 24.09 147,238
2019-05-02 DNLI Denali Therapeutics Inc. Sale 6,111 24.03 146,847
2019-05-03 DNLI Denali Therapeutics Inc. Sale 6,111 24.49 149,658
2019-04-03 DNLI Denali Therapeutics Inc. Sale 6,141 26.52 162,890
2019-04-02 DNLI Denali Therapeutics Inc. Sale 6,142 24.84 152,597
2019-04-01 DNLI Denali Therapeutics Inc. Sale 6,050 23.91 144,655
2019-03-01 DNLI Denali Therapeutics Inc. Sale 6,050 22.55 136,427
2019-03-04 DNLI Denali Therapeutics Inc. Sale 6,142 22.35 137,273
2019-03-05 DNLI Denali Therapeutics Inc. Sale 6,141 21.97 134,917
2019-02-04 DNLI Denali Therapeutics Inc. Sale 4,054 18.80 76,235
2019-02-05 DNLI Denali Therapeutics Inc. Sale 8,230 18.83 154,970
2019-02-01 DNLI Denali Therapeutics Inc. Sale 6,050 18.65 112,832
2019-01-02 DNLI Denali Therapeutics Inc. Sale 6,050 19.83 119,971
2019-01-03 DNLI Denali Therapeutics Inc. Sale 6,050 18.89 114,284
2019-01-04 DNLI Denali Therapeutics Inc. Sale 6,233 19.60 122,166
2018-12-03 DNLI Denali Therapeutics Inc. Sale 18,333 18.79 344,458
2018-11-13 DNLI Denali Therapeutics Inc. Sale 4,746 18.00 85,428
2018-11-15 DNLI Denali Therapeutics Inc. Sale 13,588 18.12 246,241
2018-10-01 DNLI Denali Therapeutics Inc. Sale 18,333 21.72 398,192
2018-09-04 DNLI Denali Therapeutics Inc. Sale 18,333 19.06 349,426
2018-08-29 DNLI Denali Therapeutics Inc. Sale 18,334 18.05 330,928

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Watts Ryan J. (President and CEO of Denali Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.